Alzheimer’s and dementia continue to be some of the most pressing health challenges worldwide. As research advances, 2026 is shaping up to be a year of breakthroughs in understanding, treating, and possibly preventing these conditions. Here are some of the most promising directions researchers are focusing on. Advances in Early Detection Early diagnosis is key …
What’s Next for Alzheimer’s and Dementia Research in 2026? Read More »
Alzheimer’s disease is a progressive neurological disorder that impacts memory, thinking, and behavior, often making daily life increasingly difficult. While there is currently no cure, clinical trials are playing a crucial role in advancing treatment options aimed at slowing cognitive decline and improving quality of life for patients. Exploring Innovative Treatments Clinical trials offer access …
In clinical research, especially in areas as critical as Alzheimer’s and dementia, the accuracy and reliability of data are essential. Ensuring data integrity not only supports regulatory compliance but also directly impacts patient safety, scientific discovery, and the advancement of treatment options for these challenging neurodegenerative conditions. Reliable Data Supports Valid Conclusions Research findings are …
The Importance of Data Integrity in Alzheimer’s and Dementia Clinical Research Read More »
Clinical trials play a crucial role in advancing research and finding new ways to prevent Alzheimer’s disease. These studies help scientists and medical professionals understand the disease, develop potential treatments, and identify lifestyle factors that may reduce risk. The Importance of Clinical Trials Clinical trials are essential for testing new medications, therapies, and preventive strategies …
Understanding the Role of Clinical Trials in Alzheimer’s Disease Prevention Read More »
Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimer’s Disease
Many aging individuals are concerned about their memory and other cognitive operations. They might be worried about learning new information more slowly or forgetting to pay a bill from time to time. There is, however, a distinction between typical forgetfulness and memory loss. Here’s what you need to know: What is normal forgetfulness and …
It can be tough to care for a loved one who has been diagnosed with Alzheimer’s disease. You are most likely filled with many questions and emotions of frustration, sadness, and worry to mention a few. PMI understands how difficult it may be, therefore here are some suggestions that might help make caring for your …
4 Tips on How to Take Care of Your Parent With Alzheimer’s Disease Read More »
When you’ve been searching for a cure for Alzheimer’s, and you haven’t seen a single success for nearly 20 years, maybe you should try something different. Really different. That makes sense to Dr. Jeffrey T. Apter. It’s why he and other researchers are looking to enroll people with mild to moderate Alzheimer’s in clinical …
A Radical New Treatment for Alzheimer’s Makes It Way to NJ Read More »
Global Medical Institutes (GMI) is an Investigative Research Company which conducts Phase I-IV human clinical trials for the pharmaceutical, biotechnology and medical devices industry through our network of wholly-owned and affiliated clinical research facilities.
CORPORATE OFFICE:
Woodlands Professional Buildings
256 Bunn Drive, Suite 6 Princeton, NJ 08540
OFFICE HOURS:
Mon-Fri: 9:00 AM – 5:30 PM
Sat-Sun: Closed
CONTACT INFO:
Phone: (609) 921-6050
Copyright © 2024 Global Medical Institutes
Privacy Policy | Terms of Service | Disclaimer
